Brookdale Senior Living (BKD) Financials

$13.28 +0.25 (+1.88%)

Closing price 03:59 PM Eastern

Extended Trading

$13.20 -0.08 (-0.60%)

As of 07:47 PM Eastern

Annual Income Statements for Brookdale Senior Living

This table shows Brookdale Senior Living's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-457	-404	-571	-528	-268	82	-99	-238	-189	-202	-263
Consolidated Net Income / (Loss)	-458	-405	-572	-528	-268	82	-99	-238	-189	-202	-263
Net Income / (Loss) Continuing Operations	-458	-405	-572	-528	-268	82	-99	-238	-189	-202	-263
Total Pre-Tax Income	-550	-399	-588	-578	-271	87	-108	-240	-180	-197	-265
Total Operating Income	-165	-31	-270	-594	-44	-98	-217	-43	18	47	13
Total Gross Profit	1,448	1,440	914	765	607	797	327	2,678	2,877	2,983	3,054
Total Revenue	4,961	4,977	4,747	4,531	4,057	3,540	2,758	2,825	3,016	3,125	3,194
Operating Revenue	4,961	4,977	4,747	4,531	4,057	3,540	2,758	2,825	3,016	3,125	3,194
Total Cost of Revenue	3,512	3,537	3,833	3,767	3,450	2,743	2,432	147	139	143	141
Operating Cost of Revenue	3,512	3,537	3,833	3,767	3,450	2,743	2,432	147	139	143	141
Total Operating Expenses	1,614	1,471	1,184	1,359	651	895	544	2,721	2,858	2,936	3,040
Selling, General & Admin Expense	371	313	278	259	219	207	185	2,252	2,309	2,369	2,411
Depreciation Expense	733	520	482	447	379	359	338	347	343	358	356
Other Operating Expenses / (Income)	368	374	-	162	-	224	-2.00	165	202	201	200
Impairment Charge	58	249	410	490	49	107	23	30	41	8.56	71
Other Special Charges / (Income)	76	11	14	-	3.39	-2.30	0.00	-74	-36	0.00	1.77
Total Other Income / (Expense), net	-385	-368	-318	16	-226	185	109	-197	-199	-244	-278
Interest Expense	395	395	338	292	254	198	197	214	242	274	293
Interest & Investment Income	0.80	4.59	-10	1.04	5.32	2.69	12	-3.85	19	19	12
Other Income / (Expense), net	9.03	22	31	307	22	380	295	20	24	11	2.62
Income Tax Expense	-92	5.38	-17	-49	-2.27	5.35	-8.16	-1.56	8.78	4.65	-1.95
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.68	-0.24	-0.19	-0.09	-0.56	-0.07	-0.07	0.09	-0.06	-0.06	-0.05
Basic Earnings per Share	($2.48)	($2.18)	($3.07)	($2.82)	($1.44)	$0.45	($0.54)	($1.25)	($0.84)	($0.89)	($1.12)
Weighted Average Basic Shares Outstanding	184.33M	185.65M	186.16M	187.47M	185.91M	183.50M	184.98M	190.46M	225.21M	227.53M	235.18M
Diluted Earnings per Share	($2.48)	($2.18)	($3.07)	($2.82)	($1.44)	$0.44	($0.54)	($1.25)	($0.84)	($0.89)	($1.12)
Weighted Average Diluted Shares Outstanding	184.33M	185.65M	186.16M	187.47M	185.91M	184.39M	184.98M	190.46M	225.21M	227.53M	235.18M
Weighted Average Basic & Diluted Shares Outstanding	184.33M	185.65M	186.16M	187.47M	185.91M	183.46M	185.58M	187.20M	189.34M	200.19M	237.79M

This table shows Brookdale Senior Living's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-49	-91	-30	-38	-51	-84	-65	-43	-115	-40	-6.89
Consolidated Net Income / (Loss)	-49	-91	-30	-38	-51	-84	-65	-43	-115	-40	-6.90
Net Income / (Loss) Continuing Operations	-49	-91	-30	-38	-51	-84	-65	-43	-115	-40	-6.90
Total Pre-Tax Income	-51	-81	-30	-37	-50	-80	-66	-43	-115	-41	-7.33
Total Operating Income	-6.34	-24	19	19	10	-2.14	30	15	-54	23	52
Total Gross Profit	185	2,318	747	742	746	2,375	780	778	778	717	728
Total Revenue	757	754	783	778	784	781	814	813	813	754	765
Operating Revenue	757	754	783	778	784	781	814	813	813	754	765
Total Cost of Revenue	572	-1,564	36	35	38	-1,594	34	35	35	37	37
Operating Cost of Revenue	572	-1,564	36	35	38	-1,594	34	35	35	37	37
Total Operating Expenses	191	2,343	728	723	736	2,377	750	763	832	695	676
Selling, General & Admin Expense	43	2,172	588	584	593	2,232	605	617	618	571	557
Depreciation Expense	86	87	86	88	90	94	91	93	95	77	73
Other Operating Expenses / (Income)	53	53	51	51	52	46	53	53	52	43	44
Impairment Charge	9.09	31	1.71	0.00	0.93	5.92	1.79	0.58	63	6.29	6.12
Other Special Charges / (Income)	0.00	-	-	0.00	0.00	-	0.00	-0.04	4.34	-	-4.03
Total Other Income / (Expense), net	-44	-57	-49	-56	-60	-78	-95	-58	-61	-64	-59
Interest Expense	60	63	61	61	64	88	99	63	64	67	64
Interest & Investment Income	4.90	4.54	4.78	4.71	4.66	5.01	3.65	2.92	3.02	2.80	3.11
Other Income / (Expense), net	11	1.77	7.13	0.05	-1.14	4.69	0.22	2.09	0.17	0.15	1.42
Income Tax Expense	-1.88	9.81	-0.04	0.45	0.68	3.56	-0.68	-0.27	0.17	-1.17	-0.43
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.02	-0.01	-0.02	-0.02	-0.01	-0.02	-0.01	-0.02	-0.01	-0.01	-0.01
Basic Earnings per Share	($0.22)	($0.40)	($0.13)	($0.17)	($0.22)	($0.37)	($0.28)	($0.18)	($0.48)	($0.18)	($0.03)
Weighted Average Basic Shares Outstanding	225.42M	225.21M	225.89M	226.79M	228.12M	227.53M	230.68M	234.74M	237.49M	235.18M	238.11M
Diluted Earnings per Share	($0.22)	($0.40)	($0.13)	($0.17)	($0.22)	($0.37)	($0.28)	($0.18)	($0.48)	($0.18)	($0.03)
Weighted Average Diluted Shares Outstanding	225.42M	225.21M	225.89M	226.79M	228.12M	227.53M	230.68M	234.74M	237.49M	235.18M	238.11M
Weighted Average Basic & Diluted Shares Outstanding	188.24M	189.34M	193.01M	197.20M	199.21M	200.19M	234.35M	237.49M	237.66M	237.79M	238.79M

This table details how cash moves in and out of Brookdale Senior Living's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-16	123	5.22	168	-149	163	-27	36	-125	30	-37
Net Cash From Operating Activities	292	374	378	204	216	206	-95	3.28	163	166	218
Net Cash From Continuing Operating Activities	292	374	378	204	216	206	-95	3.28	163	166	218
Net Income / (Loss) Continuing Operations	-458	-405	-572	-528	-268	82	-99	-238	-189	-202	-263
Consolidated Net Income / (Loss)	-458	-405	-572	-528	-268	82	-99	-238	-189	-202	-263
Depreciation Expense	737	530	495	456	384	365	345	354	350	368	370
Amortization Expense	12	22	13	4.87	-1.63	-2.12	-1.76	-2.31	-0.73	0.00	0.00
Non-Cash Adjustments To Reconcile Net Income	111	303	444	329	56	-395	-278	-67	-46	-15	108
Changes in Operating Assets and Liabilities, net	-109	-77	-2.19	-58	47	155	-60	-43	48	16	2.37
Net Cash From Investing Activities	-569	172	-602	289	-226	-425	181	-67	-113	-278	-456
Net Cash From Continuing Investing Activities	-569	172	-602	289	-226	-425	181	-67	-113	-278	-456
Purchase of Property, Plant & Equipment	-411	-346	-219	-497	-305	-658	-177	-203	-234	-310	-513
Acquisitions	-261	-13	-199	-9.12	-4.35	-4.08	-5.44	-0.22	-7.59	0.00	0.00
Purchase of Investments	0.00	0.00	-341	-15	-186	-378	-362	-265	-187	-59	-3.83
Sale of Property, Plant & Equipment	49	298	71	500	93	331	334	4.65	84	7.02	26
Sale and/or Maturity of Investments	9.05	219	80	309	178	280	390	401	207	81	26
Other Investing Activities, net	44	14	6.44	1.16	-0.86	3.57	1.70	-4.14	24	3.22	8.65
Net Cash From Financing Activities	261	-422	229	-325	-139	383	-114	100	-174	142	201
Net Cash From Continuing Financing Activities	261	-422	229	-325	-139	383	-114	100	-174	142	201
Repayment of Debt	-1,500	-2,067	-1,171	-1,113	-434	-724	-446	-289	-378	-620	-711
Issuance of Debt	1,763	1,666	1,409	808	322	1,129	353	254	206	766	918
Other Financing Activities, net	-2.47	-12	-8.62	-16	-3.31	-4.04	-21	-4.29	-1.92	-3.44	-6.47

This table details how cash moves in and out of Brookdale Senior Living's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-5.31	-54	46	-33	-30	48	-64	7.41	7.77	12	-9.36
Net Cash From Operating Activities	46	29	-1.15	56	66	45	23	84	77	35	21
Net Cash From Continuing Operating Activities	46	29	-1.15	56	66	45	23	84	77	35	21
Net Income / (Loss) Continuing Operations	-49	-91	-30	-38	-51	-84	-65	-43	-115	-40	-6.90
Consolidated Net Income / (Loss)	-49	-91	-30	-38	-51	-84	-65	-43	-115	-40	-6.90
Depreciation Expense	88	89	88	90	92	96	95	97	99	81	77
Non-Cash Adjustments To Reconcile Net Income	-9.03	24	-15	-9.42	-4.75	14	37	-3.21	65	9.37	6.39
Changes in Operating Assets and Liabilities, net	16	6.98	-45	12	30	19	-43	33	28	-15	-56
Net Cash From Investing Activities	-32	22	-6.95	-68	-58	-145	-327	-50	-34	-45	-30
Net Cash From Continuing Investing Activities	-32	22	-6.95	-68	-58	-145	-327	-50	-34	-45	-30
Purchase of Property, Plant & Equipment	-65	-59	-44	-52	-55	-159	-353	-54	-42	-64	-46
Purchase of Investments	-53	-20	-0.63	-27	-20	-11	0.00	-0.51	-0.88	-0.26	-4.94
Sale of Property, Plant & Equipment	0.12	40	0.85	6.17	-	-	0.00	1.05	7.09	18	22
Sale and/or Maturity of Investments	83	55	35	4.47	16	26	20	1.30	1.27	1.16	0.00
Other Investing Activities, net	11	5.05	2.57	-0.05	1.53	-0.84	6.09	2.23	-0.08	0.14	-0.38
Net Cash From Financing Activities	-19	-105	54	-20	-39	147	240	-26	-35	22	-0.51
Net Cash From Continuing Financing Activities	-19	-105	54	-20	-39	147	240	-26	-35	22	-0.51
Repayment of Debt	-19	-285	-23	-21	-222	-354	-76	-26	-33	-575	-225
Issuance of Debt	-	180	81	0.35	183	502	321	0.07	0.04	597	232
Other Financing Activities, net	-0.02	-0.04	-3.40	-0.01	-0.02	-0.01	-4.76	-0.01	-1.41	-0.30	-7.61

This table presents Brookdale Senior Living's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	10,049	9,218	7,675	6,467	7,194	6,902	6,410	5,937	5,573	6,336	5,952
Total Current Assets	498	620	902	774	596	774	699	637	478	513	554
Cash & Equivalents	88	216	223	398	240	380	347	399	278	309	279
Restricted Cash	33	33	37	28	27	28	27	28	41	40	33
Short-Term Investments	-	0.00	292	15	69	173	182	49	30	20	0.00
Accounts Receivable	144	142	129	134	134	109	51	56	48	52	68
Prepaid Expenses	123	131	115	106	84	67	88	106	81	92	97
Other Current Assets	-	-	-	-	-	-	-	-	-	0.00	77
Plant, Property, & Equipment, net	8,031	7,379	5,852	0.00	0.00	0.00	4,904	4,536	4,331	4,594	4,273
Total Noncurrent Assets	1,519	1,219	921	5,693	6,598	6,128	807	764	764	1,228	1,126
Goodwill	726	705	506	154	154	154	27	27	27	27	27
Other Noncurrent Operating Assets	259	235	195	5,436	1,278	844	648	632	707	1,170	1,068
Other Noncurrent Nonoperating Assets	33	28	23	24	35	57	64	48	30	31	31
Total Liabilities & Shareholders' Equity	10,049	9,218	7,675	6,467	7,194	6,902	6,410	5,937	5,573	6,336	5,952
Total Liabilities	7,590	7,140	6,145	5,449	6,496	6,099	5,711	5,353	5,168	6,122	5,996
Total Current Liabilities	840	731	1,096	773	1,047	691	632	641	600	580	568
Short-Term Debt	236	215	603	294	339	69	212	243	234	152	152
Accounts Payable	128	77	92	95	105	71	76	71	67	66	75
Accrued Expenses	373	328	330	298	267	288	255	237	243	264	273
Current Deferred Revenue	99	107	68	62	79	97	67	66	56	61	66
Other Current Liabilities	-	-	-	23	257	166	22	24	1.08	37	1.21
Total Noncurrent Liabilities	6,750	6,409	5,049	4,676	5,449	5,408	5,079	4,712	4,568	5,542	5,428
Long-Term Debt	3,769	3,414	3,375	3,346	3,216	3,847	3,778	3,784	3,656	4,022	4,215
Capital Lease Obligations	2,427	2,416	1,164	851	771	544	532	225	151	267	24
Noncurrent Deferred & Payable Income Tax Liabilities	69	81	71	18	15	9.56	-	0.00	5.99	9.60	6.32
Other Noncurrent Operating Liabilities	217	231	215	197	1,446	1,008	769	703	756	1,243	1,182
Total Equity & Noncontrolling Interests	2,459	2,078	1,530	1,018	699	803	700	584	405	214	-43
Total Preferred & Common Equity	2,459	2,078	1,531	1,019	696	800	697	583	404	212	-45
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,459	2,078	1,531	1,019	696	800	697	583	404	212	-45
Common Stock	4,071	4,104	4,128	4,153	4,174	4,214	4,211	4,334	4,344	4,355	4,361
Retained Earnings	-1,565	-1,970	-2,541	-3,069	-3,393	-3,311	-3,410	-3,649	-3,838	-4,040	-4,303
Treasury Stock	-47	-56	-56	-65	-85	-103	-103	-103	-103	-103	-103
Noncontrolling Interest	-0.16	-0.25	-0.44	-0.49	2.37	2.30	2.22	1.55	1.49	1.43	1.38

This table presents Brookdale Senior Living's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	6,094	5,886	5,905	5,829	5,542	5,451	5,939	6,206	6,141	6,013	5,898
Total Current Assets	581	666	617	594	516	493	474	454	467	537	553
Cash & Equivalents	299	362	337	332	319	290	255	240	252	253	265
Restricted Cash	37	29	35	41	46	44	49	38	37	42	31
Short-Term Investments	90	69	96	66	0.00	20	30	0.00	0.00	0.00	4.94
Accounts Receivable	52	53	48	48	50	50	53	58	56	68	64
Prepaid Expenses	104	130	101	95	102	89	87	118	113	105	112
Other Current Assets	0.00	24	-	13	-	-	-	-	9.71	69	75
Plant, Property, & Equipment, net	4,802	4,493	4,428	4,372	4,294	4,256	4,641	4,546	4,500	4,324	4,231
Total Noncurrent Assets	711	726	859	863	733	702	824	1,206	1,174	1,152	1,114
Goodwill	27	27	27	27	27	27	27	27	27	27	27
Other Noncurrent Operating Assets	565	598	744	746	674	646	769	1,140	1,112	1,089	1,050
Other Noncurrent Nonoperating Assets	58	45	37	30	31	29	28	38	34	36	37
Total Liabilities & Shareholders' Equity	6,094	5,886	5,905	5,829	5,542	5,451	5,939	6,206	6,141	6,013	5,898
Total Liabilities	5,601	5,345	5,365	5,336	5,167	5,109	5,645	6,058	6,035	6,018	5,952
Total Current Liabilities	657	707	649	898	614	622	584	556	566	638	535
Short-Term Debt	220	266	242	495	262	260	202	166	151	185	159
Accounts Payable	78	89	95	77	74	75	73	73	83	85	84
Accrued Expenses	262	238	242	260	218	232	249	250	268	305	224
Current Deferred Revenue	74	70	69	65	58	54	59	66	62	62	66
Other Current Liabilities	24	25	1.00	1.03	1.10	1.12	1.16	1.23	1.25	1.28	1.13
Total Noncurrent Liabilities	4,944	4,638	4,716	4,437	4,553	4,487	5,061	5,502	5,469	5,380	5,418
Long-Term Debt	3,759	3,772	3,761	3,493	3,692	3,679	3,654	4,248	4,232	4,159	4,224
Capital Lease Obligations	523	218	151	151	150	150	603	25	25	25	24
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	-	-	5.56	5.63	5.94	8.45	7.70	7.38	5.33
Other Noncurrent Operating Liabilities	662	647	805	794	704	652	798	1,220	1,204	1,189	1,164
Total Equity & Noncontrolling Interests	493	541	539	493	375	342	294	148	107	-5.34	-55
Total Preferred & Common Equity	491	539	538	492	374	340	293	147	105	-6.73	-56
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	491	539	538	492	374	340	293	147	105	-6.73	-56
Common Stock	4,217	4,336	4,338	4,341	4,344	4,348	4,352	4,354	4,356	4,359	4,356
Retained Earnings	-3,623	-3,693	-3,698	-3,747	-3,867	-3,905	-3,956	-4,105	-4,148	-4,263	-4,309
Treasury Stock	-103	-103	-103	-103	-103	-103	-103	-103	-103	-103	-103
Noncontrolling Interest	1.56	1.53	1.52	1.50	1.47	1.46	1.45	1.42	1.40	1.39	1.36

This table displays calculated financial ratios and metrics derived from Brookdale Senior Living's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	29.46%	0.33%	-4.62%	-4.54%	-10.47%	-12.74%	-22.09%	2.43%	6.74%	3.64%	2.19%
EBITDA Growth	26.42%	-8.37%	-50.50%	-35.38%	107.16%	79.53%	-34.82%	-21.75%	19.16%	8.26%	-9.03%
EBIT Growth	-93.22%	94.08%	-2,491.73%	-19.78%	92.16%	1,355.17%	-72.49%	-128.74%	291.25%	34.15%	-71.85%
NOPAT Growth	-94.58%	81.19%	-768.79%	-120.06%	92.51%	-194.40%	-65.60%	80.32%	143.13%	152.70%	-70.99%
Net Income Growth	-206.61%	11.68%	-41.26%	7.57%	49.18%	130.52%	-221.26%	-139.87%	20.67%	-6.84%	-30.08%
EPS Growth	-145.54%	12.10%	-40.83%	8.14%	48.94%	130.56%	-222.73%	-131.48%	32.80%	-5.95%	-25.84%
Operating Cash Flow Growth	20.49%	27.80%	1.26%	-46.09%	6.10%	-4.97%	-146.02%	103.47%	4,865.65%	2.00%	31.20%
Free Cash Flow Firm Growth	104.71%	165.86%	134.05%	-65.87%	-42.14%	-134.46%	24.81%	410.21%	-16.04%	-176.55%	266.35%
Invested Capital Growth	-4.19%	-8.18%	-22.66%	-16.00%	-6.76%	0.27%	-1.60%	-6.02%	-4.48%	4.64%	-5.88%
Revenue Q/Q Growth	-0.33%	-0.54%	95.71%	-35.20%	-1.99%	-3.66%	-7.02%	2.05%	1.82%	0.85%	-0.83%
EBITDA Q/Q Growth	-3.59%	-21.89%	211.46%	276.21%	-38.03%	5.35%	-12.80%	38.09%	-12.65%	8.16%	1.22%
EBIT Q/Q Growth	29.58%	-106.04%	45.13%	34.18%	-111.98%	16.44%	-43.54%	79.76%	-57.01%	77.61%	472.89%
NOPAT Q/Q Growth	28.43%	-122.46%	40.13%	-9.00%	6.92%	25.39%	-35.21%	65.12%	-73.06%	90.45%	217.47%
Net Income Q/Q Growth	-17.28%	-30.39%	56.69%	-193.20%	-488.31%	135.74%	-60.83%	19.04%	-53.03%	3.46%	14.33%
EPS Q/Q Growth	-9.25%	-30.54%	33.26%	18.26%	-500.00%	144.44%	-42.11%	18.30%	-52.73%	3.26%	14.50%
Operating Cash Flow Q/Q Growth	1.52%	1.68%	-3.16%	-19.87%	33.77%	-6.62%	-257.06%	111.11%	91.52%	10.58%	-4.66%
Free Cash Flow Firm Q/Q Growth	341.34%	-18.92%	5.02%	-24.92%	125.09%	-107.33%	-135.52%	226.73%	-48.22%	41.89%	-26.24%
Invested Capital Q/Q Growth	-4.10%	-4.04%	-4.33%	-2.51%	-26.20%	-1.61%	4.22%	-4.38%	-0.98%	-3.12%	-0.68%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	29.20%	28.93%	19.26%	16.87%	14.96%	22.52%	11.84%	94.78%	95.38%	95.43%	95.60%
EBITDA Margin	11.94%	10.90%	5.66%	3.83%	8.86%	18.24%	15.26%	11.65%	13.01%	13.59%	12.10%
Operating Margin	-3.33%	-0.62%	-5.69%	-13.11%	-1.10%	-2.76%	-7.87%	-1.51%	0.61%	1.49%	0.42%
EBIT Margin	-3.15%	-0.19%	-5.05%	-6.33%	-0.55%	7.97%	2.82%	-0.79%	1.42%	1.83%	0.50%
Profit (Net Income) Margin	-9.24%	-8.13%	-12.04%	-11.66%	-6.62%	2.31%	-3.60%	-8.44%	-6.27%	-6.46%	-8.23%
Tax Burden Percent	83.25%	101.35%	97.19%	91.44%	99.16%	93.87%	92.41%	99.35%	104.87%	102.35%	99.26%
Interest Burden Percent	352.40%	4,320.04%	245.53%	201.39%	1,204.02%	30.93%	-138.48%	1,074.86%	-422.37%	-344.65%	-1,642.04%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	6.13%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-1.37%	-0.27%	-2.81%	-7.71%	-0.65%	-1.99%	-3.33%	-0.68%	0.31%	0.78%	0.23%
ROIC Less NNEP Spread (ROIC-NNEP)	-7.31%	-7.05%	-10.59%	-10.44%	-6.74%	2.52%	-1.95%	-6.24%	-5.20%	-5.31%	-6.50%
Return on Net Nonoperating Assets (RNNOA)	-15.79%	-17.56%	-28.87%	-33.75%	-30.62%	12.91%	-9.90%	-36.45%	-38.53%	-66.04%	-308.38%
Return on Equity (ROE)	-17.16%	-17.84%	-31.69%	-41.46%	-31.27%	10.92%	-13.23%	-37.13%	-38.22%	-65.26%	-308.16%
Cash Return on Invested Capital (CROIC)	2.91%	8.25%	22.75%	9.68%	6.35%	-2.26%	-1.71%	5.52%	4.90%	-3.75%	6.28%
Operating Return on Assets (OROA)	-1.53%	-0.10%	-2.84%	-4.06%	-0.33%	4.00%	1.17%	-0.36%	0.74%	0.96%	0.26%
Return on Assets (ROA)	-4.48%	-4.20%	-6.77%	-7.47%	-3.93%	1.16%	-1.49%	-3.86%	-3.29%	-3.39%	-4.28%
Return on Common Equity (ROCE)	-17.16%	-17.84%	-31.69%	-41.48%	-31.24%	10.88%	-13.19%	-37.02%	-38.11%	-64.95%	-303.09%
Return on Equity Simple (ROE_SIMPLE)	-18.63%	-19.47%	-37.34%	-51.86%	-38.56%	10.24%	-14.25%	-40.91%	-46.84%	-95.07%	0.00%
Net Operating Profit after Tax (NOPAT)	-116	-22	-189	-416	-31	-92	-152	-30	13	33	9.45
NOPAT Margin	-2.33%	-0.44%	-3.98%	-9.18%	-0.77%	-2.59%	-5.51%	-1.06%	0.43%	1.04%	0.30%
Net Nonoperating Expense Percent (NNEP)	5.94%	6.78%	7.78%	2.73%	6.09%	-4.51%	-1.38%	5.56%	5.51%	6.09%	6.73%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-0.62%	0.29%	0.70%	0.22%
Cost of Revenue to Revenue	70.80%	71.07%	80.74%	83.13%	85.04%	77.48%	88.16%	5.22%	4.62%	4.57%	4.40%
SG&A Expenses to Revenue	7.47%	6.30%	5.86%	5.73%	5.41%	5.84%	6.70%	79.71%	76.55%	75.80%	75.49%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	32.53%	29.56%	24.94%	29.99%	16.06%	25.28%	19.71%	96.30%	94.77%	93.94%	95.18%
Earnings before Interest and Taxes (EBIT)	-156	-9.24	-240	-287	-22	282	78	-22	43	57	16
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	592	543	269	174	360	646	421	329	392	425	386
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.39	1.11	1.18	1.23	1.94	1.01	1.37	0.88	2.71	4.72	0.00
Price to Tangible Book Value (P/TBV)	2.13	1.79	1.89	1.55	2.49	1.26	1.43	0.92	2.91	5.41	0.00
Price to Revenue (P/Rev)	0.69	0.46	0.38	0.28	0.33	0.23	0.35	0.18	0.36	0.32	0.80
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	9.91	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	10.10%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.13	1.05	1.07	1.07	1.16	1.02	1.07	0.99	1.18	1.19	1.66
Enterprise Value to Revenue (EV/Rev)	1.89	1.60	1.32	1.17	1.31	1.32	1.76	1.50	1.59	1.62	2.08
Enterprise Value to EBITDA (EV/EBITDA)	15.79	14.63	23.34	30.42	14.80	7.26	11.54	12.85	12.20	11.95	17.20
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	16.61	62.55	0.00	112.19	88.64	412.20
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	371.55	155.84	703.25
Enterprise Value to Operating Cash Flow (EV/OCF)	31.98	21.25	16.57	25.89	24.59	22.80	0.00	1,290.04	29.39	30.54	30.48
Enterprise Value to Free Cash Flow (EV/FCFF)	38.06	12.15	4.10	10.12	17.62	0.00	0.00	17.44	23.50	0.00	25.61
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.62	2.91	3.36	4.41	6.19	5.56	6.46	7.28	9.97	20.76	-101.24
Long-Term Debt to Equity	2.52	2.81	2.97	4.12	5.71	5.47	6.16	6.86	9.40	20.05	-97.73
Financial Leverage	2.16	2.49	2.73	3.23	4.54	5.12	5.08	5.84	7.41	12.44	47.44
Leverage Ratio	3.83	4.25	4.68	5.55	7.96	9.39	8.86	9.62	11.63	19.24	72.06
Compound Leverage Factor	13.50	183.47	11.50	11.18	95.79	2.90	-12.27	103.38	-49.14	-66.30	-1,183.21
Debt to Total Capital	72.35%	74.42%	77.07%	81.52%	86.10%	84.75%	86.60%	87.92%	90.89%	95.40%	101.00%
Short-Term Debt to Total Capital	2.65%	2.65%	9.03%	5.34%	6.75%	1.31%	4.06%	5.02%	5.27%	3.26%	3.50%
Long-Term Debt to Total Capital	69.70%	71.77%	68.04%	76.17%	79.34%	83.44%	82.55%	82.90%	85.62%	92.14%	97.50%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	-0.01%	-0.01%	0.05%	0.04%	0.04%	0.03%	0.03%	0.03%	0.03%
Common Equity to Total Capital	27.66%	25.58%	22.94%	18.49%	13.86%	15.21%	13.36%	12.05%	9.08%	4.56%	-1.03%
Debt to EBITDA	10.86	11.14	19.14	25.88	12.03	6.91	10.75	12.91	10.30	10.45	11.36
Net Debt to EBITDA	10.03	10.37	16.61	23.18	11.04	6.00	9.26	11.30	9.41	9.59	10.56
Long-Term Debt to EBITDA	10.46	10.74	16.90	24.18	11.09	6.80	10.24	12.18	9.70	10.10	10.97
Debt to NOPAT	-55.62	-277.84	-27.20	-10.80	-138.90	-48.63	-29.78	-142.29	313.52	136.35	464.76
Net Debt to NOPAT	-51.37	-258.67	-23.60	-9.67	-127.44	-42.24	-25.67	-124.53	286.43	125.03	431.71
Long-Term Debt to NOPAT	-53.59	-267.94	-24.02	-10.09	-128.00	-47.88	-28.38	-134.16	295.35	131.68	448.68
Altman Z-Score	0.45	0.42	0.20	0.03	-0.06	0.07	-0.16	-0.34	-0.30	-0.28	-0.21
Noncontrolling Interest Sharing Ratio	0.01%	-0.01%	-0.02%	-0.04%	0.11%	0.31%	0.30%	0.29%	0.31%	0.47%	1.65%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.59	0.85	0.82	1.00	0.57	1.12	1.11	0.99	0.80	0.88	0.98
Quick Ratio	0.28	0.49	0.59	0.71	0.42	0.96	0.92	0.78	0.59	0.66	0.61
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	246	653	1,529	522	302	-104	-78	243	204	-156	259
Operating Cash Flow to CapEx	80.80%	780.52%	254.66%	0.00%	102.15%	62.94%	0.00%	1.65%	108.43%	54.91%	44.82%
Free Cash Flow to Firm to Interest Expense	0.62	1.66	4.52	1.79	1.19	-0.53	-0.40	1.14	0.84	-0.57	0.88
Operating Cash Flow to Interest Expense	0.74	0.95	1.12	0.70	0.85	1.04	-0.48	0.02	0.67	0.61	0.74
Operating Cash Flow Less CapEx to Interest Expense	-0.18	0.83	0.68	0.71	0.02	-0.61	0.32	-0.91	0.05	-0.50	-0.92
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.48	0.52	0.56	0.64	0.59	0.50	0.41	0.46	0.52	0.52	0.52
Accounts Receivable Turnover	33.77	34.83	35.08	34.48	30.33	29.16	34.40	52.86	57.91	62.33	53.43
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.60	0.65	0.72	0.00	0.00	0.00	0.00	0.60	0.68	0.70	0.72
Accounts Payable Turnover	34.38	34.45	45.31	40.31	34.54	31.18	33.00	2.00	2.03	2.16	2.00
Days Sales Outstanding (DSO)	10.81	10.48	10.41	10.59	12.03	12.52	10.61	6.90	6.30	5.86	6.83
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	10.62	10.60	8.06	9.05	10.57	11.71	11.06	182.21	180.14	168.61	182.65
Cash Conversion Cycle (CCC)	0.19	-0.12	2.35	1.53	1.47	0.81	-0.45	-175.30	-173.84	-162.76	-175.81
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	8,255	7,580	5,862	4,924	4,591	4,603	4,530	4,257	4,066	4,255	4,005
Invested Capital Turnover	0.59	0.63	0.71	0.84	0.85	0.77	0.60	0.64	0.72	0.75	0.77
Increase / (Decrease) in Invested Capital	-361	-675	-1,718	-938	-333	12	-74	-273	-191	189	-250
Enterprise Value (EV)	9,351	7,939	6,268	5,281	5,321	4,688	4,857	4,233	4,789	5,076	6,645
Market Capitalization	3,411	2,311	1,808	1,258	1,349	812	956	510	1,096	1,002	2,564
Book Value per Share	$13.31	$11.17	$8.21	$5.43	$3.75	$4.36	$3.76	$3.12	$2.14	$1.07	($0.19)
Tangible Book Value per Share	$8.68	$6.93	$5.13	$4.33	$2.92	$3.52	$3.62	$2.97	$2.00	$0.93	($0.30)
Total Capital	8,891	8,123	6,673	5,510	5,025	5,262	5,222	4,836	4,446	4,655	4,348
Total Debt	6,432	6,045	5,142	4,492	4,327	4,460	4,522	4,252	4,041	4,441	4,391
Total Long-Term Debt	6,197	5,830	4,540	4,197	3,987	4,391	4,310	4,009	3,807	4,289	4,239
Net Debt	5,940	5,628	4,461	4,023	3,970	3,873	3,898	3,721	3,692	4,072	4,079
Capital Expenditures (CapEx)	362	48	149	-2.56	212	327	-157	198	150	303	486
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-227	-146	-143	-146	-447	-430	-277	-237	-237	-284	-174
Debt-free Net Working Capital (DFNWC)	-107	104	409	295	-111	152	279	239	112	85	138
Net Working Capital (NWC)	-342	-112	-194	0.69	-451	83	67	-4.11	-122	-67	-14
Net Nonoperating Expense (NNE)	343	383	383	112	237	-174	-52	208	202	235	272
Net Nonoperating Obligations (NNO)	5,796	5,502	4,332	3,906	3,892	3,801	3,830	3,673	3,661	4,041	4,048
Total Depreciation and Amortization (D&A)	748	552	508	460	382	363	343	352	350	368	370
Debt-free, Cash-free Net Working Capital to Revenue	-4.58%	-2.93%	-3.01%	-3.22%	-11.02%	-12.14%	-10.06%	-8.37%	-7.85%	-9.07%	-5.46%
Debt-free Net Working Capital to Revenue	-2.15%	2.08%	8.61%	6.51%	-2.75%	4.29%	10.11%	8.45%	3.73%	2.72%	4.32%
Net Working Capital to Revenue	-6.90%	-2.24%	-4.08%	0.02%	-11.11%	2.34%	2.43%	-0.15%	-4.04%	-2.14%	-0.44%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($2.48)	($2.18)	($3.07)	($2.82)	($1.44)	$0.45	($0.54)	($1.25)	($0.84)	($0.89)	($1.12)
Adjusted Weighted Average Basic Shares Outstanding	184.89M	185.45M	186.57M	186.60M	184.26M	183.50M	184.98M	190.46M	225.21M	227.53M	235.18M
Adjusted Diluted Earnings per Share	($2.48)	($2.18)	($3.07)	($2.82)	($1.44)	$0.44	($0.54)	($1.25)	($0.84)	($0.89)	($1.12)
Adjusted Weighted Average Diluted Shares Outstanding	184.89M	185.45M	186.57M	186.60M	184.26M	184.39M	184.98M	190.46M	225.21M	227.53M	235.18M
Adjusted Basic & Diluted Earnings per Share	($2.48)	($2.18)	($3.07)	($2.82)	($1.44)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	184.33M	185.65M	186.16M	187.47M	185.91M	183.46M	185.58M	187.20M	189.34M	200.19M	237.79M
Normalized Net Operating Profit after Tax (NOPAT)	-16	163	108	-73	5.71	6.86	-136	-61	16	39	61
Normalized NOPAT Margin	-0.32%	3.27%	2.27%	-1.61%	0.14%	0.19%	-4.92%	-2.15%	0.53%	1.23%	1.90%
Pre Tax Income Margin	-11.09%	-8.02%	-12.39%	-12.75%	-6.67%	2.47%	-3.90%	-8.49%	-5.98%	-6.31%	-8.29%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.40	-0.02	-0.71	-0.98	-0.09	1.43	0.39	-0.10	0.18	0.21	0.06
NOPAT to Interest Expense	-0.29	-0.06	-0.56	-1.42	-0.12	-0.46	-0.77	-0.14	0.05	0.12	0.03
EBIT Less CapEx to Interest Expense	-1.31	-0.14	-1.15	-0.97	-0.92	-0.23	1.19	-1.03	-0.44	-0.90	-1.60
NOPAT Less CapEx to Interest Expense	-1.21	-0.18	-1.00	-1.42	-0.96	-2.12	0.03	-1.07	-0.57	-0.99	-1.63
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-2.38%	0.00%	-0.81%	-8.92%	22.12%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Brookdale Senior Living's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	237,792,413.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	237,792,413.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-0.03
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-0.02%	7.69%	3.93%	3.56%	3.55%	3.51%	3.96%	4.55%	3.70%	-3.44%	-6.02%
EBITDA Growth	-18.71%	-45.94%	19.00%	-19.73%	9.71%	47.91%	8.40%	3.64%	-55.80%	4.72%	4.62%
EBIT Growth	-81.92%	-165.82%	161.99%	-61.87%	94.43%	111.37%	12.96%	-11.55%	-688.63%	800.43%	78.55%
NOPAT Growth	-133.00%	-194.35%	146.05%	-53.45%	261.86%	91.17%	53.67%	-22.21%	-624.76%	1,168.26%	75.06%
Net Income Growth	-72.03%	-255.42%	33.62%	-733.89%	-3.94%	7.93%	-119.71%	-14.03%	-126.16%	52.37%	89.38%
EPS Growth	-46.67%	-263.64%	35.00%	-750.00%	0.00%	7.50%	-115.38%	-5.88%	-118.18%	51.35%	89.29%
Operating Cash Flow Growth	-27.96%	160.32%	-104.77%	-12.78%	45.22%	54.29%	2,142.06%	50.11%	15.15%	-23.58%	-10.75%
Free Cash Flow Firm Growth	469.28%	-40.15%	72.41%	-72.24%	-181.58%	-209.28%	-189.96%	-228.43%	215.73%	239.97%	276.27%
Invested Capital Growth	-7.76%	-4.48%	-4.03%	-2.16%	6.95%	4.64%	4.58%	3.52%	-8.19%	-5.88%	-6.01%
Revenue Q/Q Growth	0.87%	-0.37%	3.76%	-0.68%	0.85%	-0.41%	4.21%	-0.11%	0.03%	-7.26%	1.43%
EBITDA Q/Q Growth	-32.22%	-27.72%	71.59%	-4.52%	-7.35%	-2.56%	25.76%	-8.71%	-60.48%	130.84%	25.63%
EBIT Q/Q Growth	-90.70%	-579.14%	217.39%	-27.15%	-52.55%	-71.99%	1,066.48%	-42.95%	-415.75%	142.85%	131.30%
NOPAT Q/Q Growth	-115.40%	-282.41%	179.41%	-0.44%	-46.46%	-120.85%	1,482.70%	-49.60%	-461.14%	142.44%	126.60%
Net Income Q/Q Growth	-978.46%	-86.78%	67.55%	-27.59%	-34.42%	-65.45%	22.57%	33.78%	-166.59%	65.16%	82.73%
EPS Q/Q Growth	-1,000.00%	-81.82%	67.50%	-30.77%	-29.41%	-68.18%	24.32%	35.71%	-166.67%	62.50%	83.33%
Operating Cash Flow Q/Q Growth	-28.30%	-35.99%	-103.91%	4,957.77%	19.37%	-31.99%	-48.22%	257.08%	-8.42%	-54.87%	-39.53%
Free Cash Flow Firm Q/Q Growth	-7.92%	-49.03%	6.28%	-44.34%	-370.56%	31.72%	12.51%	20.54%	343.82%	-17.42%	10.18%
Invested Capital Q/Q Growth	-0.77%	-0.98%	0.45%	-0.87%	8.48%	-3.12%	0.39%	-1.88%	-3.80%	-0.68%	0.24%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	24.42%	307.29%	95.40%	26.34%	25.27%	304.16%	95.85%	95.73%	95.66%	95.14%	95.16%
EBITDA Margin	12.22%	8.86%	14.66%	14.09%	12.95%	12.67%	15.28%	13.97%	5.52%	13.74%	17.01%
Operating Margin	-0.84%	-3.21%	2.46%	2.46%	1.31%	-0.27%	3.63%	1.83%	-6.62%	3.03%	6.77%
EBIT Margin	0.62%	-2.98%	3.37%	2.47%	1.16%	0.33%	3.66%	2.09%	-6.60%	3.05%	6.95%
Profit (Net Income) Margin	-6.45%	-12.08%	-3.78%	-4.85%	-6.47%	-10.75%	-7.99%	-5.29%	-14.11%	-5.30%	-0.90%
Tax Burden Percent	96.30%	112.06%	99.87%	101.20%	101.35%	104.43%	98.97%	99.37%	100.15%	97.15%	94.15%
Interest Burden Percent	-1,080.98%	362.12%	-112.31%	-194.08%	-549.05%	-3,147.10%	-220.42%	-254.82%	213.49%	-178.92%	-13.79%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-0.41%	-1.63%	1.26%	1.29%	0.67%	-0.14%	1.92%	0.99%	-3.54%	1.64%	3.60%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.58%	-3.65%	0.10%	-0.11%	-0.83%	-2.28%	-0.27%	-0.38%	-5.44%	0.26%	2.54%
Return on Net Nonoperating Assets (RNNOA)	-12.11%	-27.08%	0.79%	-0.88%	-8.17%	-28.43%	-3.98%	-6.57%	-153.09%	12.17%	222.74%
Return on Equity (ROE)	-12.52%	-28.71%	2.04%	0.42%	-7.50%	-28.57%	-2.06%	-5.58%	-156.63%	13.81%	226.34%
Cash Return on Invested Capital (CROIC)	9.19%	4.90%	4.61%	2.32%	-6.32%	-3.75%	-3.52%	-2.57%	8.35%	6.28%	6.80%
Operating Return on Assets (OROA)	0.31%	-1.56%	1.80%	1.34%	0.61%	0.17%	1.97%	1.15%	-3.56%	1.59%	3.61%
Return on Assets (ROA)	-3.20%	-6.33%	-2.01%	-2.63%	-3.41%	-5.64%	-4.29%	-2.92%	-7.61%	-2.76%	-0.47%
Return on Common Equity (ROCE)	-12.48%	-28.62%	2.04%	0.42%	-7.47%	-28.44%	-2.05%	-5.54%	-155.10%	13.59%	219.61%
Return on Equity Simple (ROE_SIMPLE)	-25.12%	0.00%	-46.55%	-60.93%	-71.44%	0.00%	-161.81%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-4.44	-17	13	13	7.18	-1.50	21	10	-38	16	36
NOPAT Margin	-0.59%	-2.25%	1.72%	1.73%	0.92%	-0.19%	2.54%	1.28%	-4.63%	2.12%	4.74%
Net Nonoperating Expense Percent (NNEP)	1.17%	2.02%	1.16%	1.40%	1.50%	2.14%	2.19%	1.37%	1.89%	1.38%	1.05%
Return On Investment Capital (ROIC_SIMPLE)	-	-0.38%	0.30%	-	-	-0.03%	0.45%	0.23%	-0.86%	0.37%	0.83%
Cost of Revenue to Revenue	75.58%	-207.29%	4.60%	73.66%	74.73%	-204.16%	4.15%	4.27%	4.34%	4.86%	4.84%
SG&A Expenses to Revenue	5.69%	287.84%	75.15%	6.00%	5.73%	285.78%	74.32%	75.93%	75.98%	75.74%	72.76%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	25.25%	310.50%	92.95%	23.88%	23.96%	304.43%	92.21%	93.90%	102.28%	92.11%	88.39%
Earnings before Interest and Taxes (EBIT)	4.69	-22	26	19	9.12	2.55	30	17	-54	23	53
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	93	67	115	110	102	99	124	114	45	104	130
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.58	2.71	3.33	3.87	4.57	4.72	8.54	15.48	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	1.68	2.91	3.59	4.21	5.04	5.41	10.50	20.90	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.26	0.36	0.41	0.43	0.43	0.32	0.40	0.51	0.62	0.80	1.03
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.08	1.18	1.22	1.25	1.24	1.19	1.27	1.37	1.51	1.66	1.83
Enterprise Value to Revenue (EV/Rev)	1.49	1.59	1.64	1.65	1.76	1.62	1.72	1.80	1.89	2.08	2.34
Enterprise Value to EBITDA (EV/EBITDA)	9.85	12.20	12.14	13.17	13.92	11.95	12.47	13.12	15.94	17.20	18.77
Enterprise Value to EBIT (EV/EBIT)	44.56	112.19	84.53	181.78	169.56	88.64	89.26	98.39	0.00	412.20	186.26
Enterprise Value to NOPAT (EV/NOPAT)	92.49	371.55	238.75	922.02	319.66	155.84	136.09	156.20	0.00	703.25	294.57
Enterprise Value to Operating Cash Flow (EV/OCF)	52.01	29.39	36.20	39.01	36.38	30.54	28.40	26.31	26.62	30.48	34.16
Enterprise Value to Free Cash Flow (EV/FCFF)	11.25	23.50	25.94	53.25	0.00	0.00	0.00	0.00	17.30	25.61	26.12
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	8.39	9.97	10.93	11.97	15.15	20.76	29.97	41.28	-817.87	-101.24	-80.77
Long-Term Debt to Equity	7.39	9.40	10.23	11.21	14.46	20.05	28.85	39.87	-783.22	-97.73	-77.85
Financial Leverage	7.68	7.41	8.10	8.29	9.79	12.44	14.96	17.38	28.15	47.44	87.56
Leverage Ratio	12.09	11.63	12.47	12.89	14.94	19.24	22.44	25.85	41.36	72.06	129.36
Compound Leverage Factor	-130.70	42.13	-14.01	-25.02	-82.03	-605.42	-49.46	-65.87	88.30	-128.93	-17.83
Debt to Total Capital	89.35%	90.89%	91.62%	92.29%	93.81%	95.40%	96.77%	97.64%	100.12%	101.00%	101.25%
Short-Term Debt to Total Capital	10.69%	5.27%	5.85%	5.87%	4.26%	3.26%	3.62%	3.35%	4.24%	3.50%	3.66%
Long-Term Debt to Total Capital	78.66%	85.62%	85.77%	86.42%	89.55%	92.14%	93.15%	94.29%	95.88%	97.50%	97.59%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%
Common Equity to Total Capital	10.62%	9.08%	8.35%	7.68%	6.16%	4.56%	3.20%	2.33%	-0.15%	-1.03%	-1.28%
Debt to EBITDA	9.21	10.30	9.99	10.66	11.36	10.45	10.22	10.06	11.44	11.36	11.24
Net Debt to EBITDA	8.11	9.41	9.10	9.74	10.51	9.59	9.58	9.40	10.67	10.56	10.47
Long-Term Debt to EBITDA	8.11	9.70	9.35	9.98	10.84	10.10	9.84	9.71	10.96	10.97	10.83
Debt to NOPAT	86.52	313.52	196.54	745.84	260.78	136.35	111.55	119.72	-543.17	464.76	176.39
Net Debt to NOPAT	76.17	286.43	179.11	681.33	241.28	125.03	104.56	111.87	-506.46	431.71	164.34
Long-Term Debt to NOPAT	76.17	295.35	183.99	698.39	248.95	131.68	107.38	115.61	-520.15	448.68	170.01
Altman Z-Score	-0.36	-0.34	-0.29	-0.30	-0.29	-0.31	-0.30	-0.27	-0.31	-0.21	-0.13
Noncontrolling Interest Sharing Ratio	0.31%	0.31%	0.33%	0.34%	0.37%	0.47%	0.55%	0.64%	0.98%	1.65%	2.97%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.66	0.80	0.84	0.79	0.81	0.88	0.82	0.83	0.84	0.98	1.03
Quick Ratio	0.50	0.59	0.60	0.58	0.58	0.66	0.54	0.54	0.50	0.61	0.63
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	341	174	185	103	-278	-190	-166	-132	322	266	293
Operating Cash Flow to CapEx	70.67%	161.31%	-2.63%	122.60%	120.90%	28.48%	6.63%	156.43%	221.79%	75.68%	85.54%
Free Cash Flow to Firm to Interest Expense	5.66	2.74	3.04	1.68	-4.36	-2.16	-1.68	-2.09	5.04	3.97	4.61
Operating Cash Flow to Interest Expense	0.76	0.46	-0.02	0.91	1.04	0.51	0.24	1.32	1.20	0.52	0.33
Operating Cash Flow Less CapEx to Interest Expense	-0.32	0.18	-0.74	0.17	0.18	-1.29	-3.32	0.48	0.66	-0.17	-0.06
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.50	0.52	0.53	0.54	0.53	0.52	0.54	0.55	0.54	0.52	0.52
Accounts Receivable Turnover	59.79	57.91	59.56	62.69	61.66	62.33	58.70	60.31	53.43	53.43	51.45
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.65	0.68	0.69	0.71	0.69	0.70	0.71	0.73	0.72	0.72	0.72
Accounts Payable Turnover	30.99	2.03	0.00	27.06	30.70	2.16	1.91	1.77	1.74	2.00	1.83
Days Sales Outstanding (DSO)	6.10	6.30	6.13	5.82	5.92	5.86	6.22	6.05	6.83	6.83	7.09
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	11.78	180.14	0.00	13.49	11.89	168.61	191.49	205.87	209.32	182.65	199.97
Cash Conversion Cycle (CCC)	-5.67	-173.84	6.13	-7.67	-5.97	-162.76	-185.27	-199.82	-202.49	-175.81	-192.88
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,107	4,066	4,085	4,049	4,392	4,255	4,272	4,191	4,032	4,005	4,015
Invested Capital Turnover	0.69	0.72	0.73	0.75	0.73	0.75	0.76	0.77	0.76	0.77	0.76
Increase / (Decrease) in Invested Capital	-346	-191	-171	-89	285	189	187	143	-360	-250	-257
Enterprise Value (EV)	4,424	4,789	4,986	5,056	5,467	5,076	5,416	5,752	6,087	6,645	7,361
Market Capitalization	779	1,096	1,244	1,318	1,339	1,002	1,253	1,631	2,012	2,564	3,253
Book Value per Share	$2.61	$2.14	$1.66	$1.76	$1.49	$1.07	$0.73	$0.45	($0.03)	($0.19)	($0.24)
Tangible Book Value per Share	$2.47	$2.00	$1.53	$1.62	$1.35	$0.93	$0.60	$0.33	($0.14)	($0.30)	($0.35)
Total Capital	4,632	4,446	4,480	4,431	4,754	4,655	4,588	4,515	4,364	4,348	4,353
Total Debt	4,139	4,041	4,105	4,090	4,460	4,441	4,440	4,408	4,369	4,391	4,408
Total Long-Term Debt	3,644	3,807	3,843	3,829	4,257	4,289	4,274	4,257	4,184	4,239	4,249
Net Debt	3,644	3,692	3,741	3,736	4,126	4,072	4,162	4,119	4,074	4,079	4,107
Capital Expenditures (CapEx)	65	18	44	45	55	159	353	53	35	46	24
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-248	-237	-200	-223	-241	-284	-214	-236	-211	-174	-124
Debt-free Net Working Capital (DFNWC)	191	112	164	131	92	85	64	53	84	138	177
Net Working Capital (NWC)	-304	-122	-99	-129	-110	-67	-102	-98	-101	-14	18
Net Nonoperating Expense (NNE)	44	74	43	51	58	82	86	53	77	56	43
Net Nonoperating Obligations (NNO)	3,613	3,661	3,709	3,707	4,098	4,041	4,123	4,085	4,038	4,048	4,069
Total Depreciation and Amortization (D&A)	88	89	88	90	92	96	95	97	99	81	77
Debt-free, Cash-free Net Working Capital to Revenue	-8.38%	-7.85%	-6.58%	-7.25%	-7.79%	-9.07%	-6.77%	-7.40%	-6.55%	-5.46%	-3.94%
Debt-free Net Working Capital to Revenue	6.44%	3.73%	5.38%	4.26%	2.97%	2.72%	2.04%	1.66%	2.62%	4.32%	5.64%
Net Working Capital to Revenue	-10.28%	-4.04%	-3.23%	-4.21%	-3.56%	-2.14%	-3.22%	-3.08%	-3.13%	-0.44%	0.57%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.22)	($0.40)	($0.13)	($0.17)	($0.22)	($0.37)	($0.28)	($0.18)	($0.48)	($0.18)	($0.03)
Adjusted Weighted Average Basic Shares Outstanding	225.42M	225.21M	225.89M	226.79M	228.12M	227.53M	230.68M	234.74M	237.49M	235.18M	238.11M
Adjusted Diluted Earnings per Share	($0.22)	($0.40)	($0.13)	($0.17)	($0.22)	($0.37)	($0.28)	($0.18)	($0.48)	($0.18)	($0.03)
Adjusted Weighted Average Diluted Shares Outstanding	225.42M	225.21M	225.89M	226.79M	228.12M	227.53M	230.68M	234.74M	237.49M	235.18M	238.11M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	188.24M	189.34M	193.01M	197.20M	199.21M	200.19M	234.35M	237.49M	237.66M	237.79M	238.79M
Normalized Net Operating Profit after Tax (NOPAT)	1.92	4.71	15	13	7.84	2.64	22	11	9.24	20	38
Normalized NOPAT Margin	0.25%	0.62%	1.87%	1.73%	1.00%	0.34%	2.70%	1.33%	1.14%	2.70%	4.93%
Pre Tax Income Margin	-6.69%	-10.78%	-3.78%	-4.80%	-6.38%	-10.29%	-8.07%	-5.33%	-14.09%	-5.46%	-0.96%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.08	-0.35	0.43	0.31	0.14	0.03	0.30	0.27	-0.84	0.34	0.84
NOPAT to Interest Expense	-0.07	-0.27	0.22	0.22	0.11	-0.02	0.21	0.17	-0.59	0.24	0.57
EBIT Less CapEx to Interest Expense	-1.00	-0.64	-0.28	-0.43	-0.72	-1.78	-3.26	-0.58	-1.38	-0.34	0.45
NOPAT Less CapEx to Interest Expense	-1.15	-0.55	-0.49	-0.52	-0.75	-1.82	-3.35	-0.68	-1.13	-0.44	0.19
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Brookdale Senior Living Inc. (BKD) has a pattern of high gross margins paired with ongoing profitability challenges driven by a large debt load and substantial interest expense. Below is a concise, data-driven look at trends over the last four years, focusing on the four most recent years of quarterly results.

Operating cash flow has been positive in 2025 quarters, showing improving liquidity from operations. Examples: Q1 2025 net cash from continuing operating activities about $34.5M, Q2 2025 about $83.6M, Q3 2025 about $76.5M, and Q4 2025 about $34.5M.
Very high gross margins (gross profit share of revenue) in recent quarters. For instance: - Q4 2025: Total Gross Profit $717.4M on Operating Revenue $754.1M (about 95% margin) - Q3 2025: $777.8M gross profit on $813.2M revenue (about 95.7%) - Q2 2025: $778.2M gross profit on $812.9M revenue (about 95.9%) - Q1 2025: $780.1M gross profit on $813.9M revenue (about 95.9%) These margins imply strong pricing power or cost accounting alignment at the gross line.
Debt financing activity provided liquidity in late 2025. In Q4 2025, Brookdale shows issuance of debt of about $597.3M, contributing to financing activities that posted a modest net cash from financing of about $21.7M for the period.
Asset sales contributed to cash receipts in some quarters. For example, Q4 2025 shows sale of property, plant & equipment of about $18.0M (plus smaller investment sales in other periods), adding to liquidity from investing activities.

Revenue level and trend are relatively stable but mixed year over year. In 2025, quarterly operating revenue ranges around $754–$814M, with Q4 2025 at $754.1M versus Q4 2024 at $780.9M (a year-over-year dip).
Balance-sheet equity position has fluctuated, with a notable improvement by late 2025. For example, Total Common Equity was negative in some 2025 quarters (e.g., Q3 2025 showed a negative value), but by Q4 2025 it turned positive around $292.9M in Total Common Equity, indicating improved capitalization in the latest period.
Working capital and liquidity show balance-sheet stress in some periods. In Q3 2025, Total Current Assets were about $536.9M vs. Total Current Liabilities $637.8M (current ratio around 0.84), a condition that can stress near-term liquidity.

Net income remains negative across most quarters. Examples: Q4 2025 Consolidated Net Income / Loss about -$39.96M; Q3 2025 about -$114.73M; Q2 2025 about -$43.04M; Q1 2025 about -$64.99M.
Interest expense remains a major profitability drag. Quarterly interest expense runs around $60–$100M: - Q1 2025: $99.1M - Q2 2025: $63.2M - Q3 2025: $63.9M - Q4 2025: $66.9M This is on top of a large debt base (long-term debt generally in the $4.2B range in recent periods).
High leverage with a very large long-term debt load. The company carries long-term debt broadly in the $4.2–4.4B range in mid-2020s periods, contributing to ongoing interest and principal pressures on cash flow.

05/19/26 12:56 AM ETAI Generated. May Contain Errors.

Brookdale Senior Living Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Brookdale Senior Living's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Brookdale Senior Living's net income appears to be on a downward trend, with a most recent value of -$262.75 million in 2025, falling from -$458.16 million in 2015. The previous period was -$201.99 million in 2024. Check out Brookdale Senior Living's forecast to explore projected trends and price targets.

Brookdale Senior Living's total operating income in 2025 was $13.50 million, based on the following breakdown:

Total Gross Profit: $3.05 billion
Total Operating Expenses: $3.04 billion

Over the last 10 years, Brookdale Senior Living's total revenue changed from $4.96 billion in 2015 to $3.19 billion in 2025, a change of -35.6%.

Brookdale Senior Living's total liabilities were at $6.00 billion at the end of 2025, a 2.1% decrease from 2024, and a 21.0% decrease since 2015.

In the past 10 years, Brookdale Senior Living's cash and equivalents has ranged from $88.03 million in 2015 to $398.85 million in 2022, and is currently $279.12 million as of their latest financial filing in 2025.

Over the last 10 years, Brookdale Senior Living's book value per share changed from 13.31 in 2015 to -0.19 in 2025, a change of -101.4%.

Related Companies

Financial statements for NYSE:BKD last updated on 5/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Brookdale Senior Living (BKD) Financials

Financials Breakdown Chart

Key Financial Trends

Brookdale Senior Living Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Brookdale Senior Living (BKD) Financials

Annual Income Statements for Brookdale Senior Living

Quarterly Income Statements for Brookdale Senior Living

Annual Cash Flow Statements for Brookdale Senior Living

Quarterly Cash Flow Statements for Brookdale Senior Living

Annual Balance Sheets for Brookdale Senior Living

Quarterly Balance Sheets for Brookdale Senior Living

Annual Metrics And Ratios for Brookdale Senior Living

Quarterly Metrics And Ratios for Brookdale Senior Living

Financials Breakdown Chart

Key Financial Trends

Brookdale Senior Living Financials - Frequently Asked Questions

When does Brookdale Senior Living's financial year end?

How has Brookdale Senior Living's net income changed over the last 10 years?

What is Brookdale Senior Living's operating income?

How has Brookdale Senior Living's revenue changed over the last 10 years?

How much debt does Brookdale Senior Living have?

How much cash does Brookdale Senior Living have?

How has Brookdale Senior Living's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools